News & Press Release

• 10.09.24

  Sirsram Medical announces NMPA approval for DAXXIFY®, Marking the introduction of the world’s first and only peptide-powered botulinum toxin product to Mainland China

• 21.08.24

  Sisram Medical Announces First-Half 2024 Financial Results

• 15.08.24

  Sisram Medical Ltd. to Hold H1 2024 Financial Results Conference Call on August 22 at 830 a.m. ET.

• 20.03.24

  Sisram Medical Announces 2023 Annual Results

• 14.03.24

  Sisram Medical to Hold FY2023 Financial Results Conference Call on March 21

• 14.11.23

  Alma, a Sisram Medical Company, Reinforces its APAC Leadership with the Establishment of a New Venture in Japan

• 23.08.23

  Sisram Medical Announces H1 2023 Financial Results

• 17.08.23

  Sisram Medical Ltd. to Hold H1 2023 Financial Results Conference Call on August 24 at 8:00 a.m. ET

• 25.07.23

  Alma, a Sisram Medical Company, Announces the Launch of Alma Veil™ for the U.S. Market

• 03.07.23

  Alma, a Sisram Medical company, is establishing a direct operation in China after completing the acquisition of PhotonMed